Polysaccharides in colon-specific drug delivery

Citation
Vr. Sinha et R. Kumria, Polysaccharides in colon-specific drug delivery, INT J PHARM, 224(1-2), 2001, pp. 19-38
Citations number
139
Categorie Soggetti
Pharmacology & Toxicology
Journal title
INTERNATIONAL JOURNAL OF PHARMACEUTICS
ISSN journal
03785173 → ACNP
Volume
224
Issue
1-2
Year of publication
2001
Pages
19 - 38
Database
ISI
SICI code
0378-5173(20010814)224:1-2<19:PICDD>2.0.ZU;2-P
Abstract
Natural polysaccharides are now extensively used for the development of sol id dosage forms for delivery of drug to the colon. The rationale for the de velopment of a polysaccharide based delivery system for colon is the presen ce of large amounts of polysaccharidases in the human colon as the colon is inhabited by a large number and variety of bacteria which secrete many enz ymes e.g. beta -D-glucosidase, beta -D-galactosidase, amylase, pectinase. x ylanase, beta -D-xylosidase, dextranase, etc. Various major approaches util izing polysaccharides for colon-specific delivery are fermentable coating o f the drug core, embedding of the drug in biodegradable matrix, formulation of drug-saccharide conjugate (prodrugs). A large number of polysaccharides have already been studied for their potential as colon-specific drug carri er systems, such as chitosan, pectin, chondroitin sulphate, cyclodextrin, d extrans, guar gum, inulin, amylose and locust bean gum. Recent efforts and approaches exploiting these polysaccharides in colon-specific drug delivery are discussed. (C) 2001 Elsevier Science B.V. All rights reserved.